Rockwell Capex To Revenue from 2010 to 2024

RMTI Stock  USD 2.29  0.07  3.15%   
Rockwell Medical's Capex To Revenue is decreasing with slightly volatile movements from year to year. Capex To Revenue is predicted to flatten to 0. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.00339664
Current Value
0.003227
Quarterly Volatility
0.04436463
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 M, Interest Expense of 2.2 M or Total Revenue of 45.6 M, as well as many indicators such as Price To Sales Ratio of 0.5, Dividend Yield of 0.0 or PTB Ratio of 1.97. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
  
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Latest Rockwell Medical's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Rockwell Medical over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Rockwell Medical's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rockwell Medical's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

Rockwell Capex To Revenue Regression Statistics

Arithmetic Mean0.02
Geometric Mean0.01
Coefficient Of Variation188.69
Mean Deviation0.02
Median0.01
Standard Deviation0.04
Sample Variance0
Range0.1786
R-Value(0.47)
Mean Square Error0
R-Squared0.22
Significance0.08
Slope(0)
Total Sum of Squares0.03

Rockwell Capex To Revenue History

2024 0.003227
2023 0.003397
2022 0.003859
2021 0.008429
2020 0.0168
2019 0.0218
2018 0.0157

About Rockwell Medical Financial Statements

Investors use fundamental indicators, such as Rockwell Medical's Capex To Revenue, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year

Currently Active Assets on Macroaxis

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.04)
Revenue Per Share
3.041
Quarterly Revenue Growth
0.429
Return On Assets
(0.04)
Return On Equity
(0.29)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.